Alembic Pharmaceuticals Limited
NSE:APLLTD.NS
1038.2 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||
Current Assets: | ||||||||||||||
Cash & Cash Equivalents
| 1,265.7 | 754.8 | 610.9 | 980.6 | 718.4 | 1,990.7 | 837.5 | 1,530.8 | 4,508.291 | 268.256 | 239.613 | 161.06 | 470.805 | 62.893 |
Short Term Investments
| 271.3 | 166.4 | 316.2 | 1,869.7 | 0 | 0 | 121.8 | 503.4 | -846.162 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 1,265.7 | 921.2 | 610.9 | 2,850.3 | 718.4 | 1,990.7 | 959.3 | 1,530.8 | 4,508.291 | 268.256 | 239.613 | 161.06 | 470.805 | 62.893 |
Net Receivables
| 10,248.4 | 11,291.1 | 11,900.1 | 8,067.3 | 12,033.6 | 6,152.6 | 7,268.1 | 5,352.4 | 4,781.544 | 3,611.673 | 2,733.729 | 2,328.708 | 0 | 0 |
Inventory
| 16,435.4 | 14,752.7 | 16,097 | 14,861.5 | 11,875.3 | 9,672.6 | 7,339.3 | 6,327.5 | 5,775.798 | 3,827.706 | 3,107.782 | 2,668.333 | 2,587.415 | 2,192.319 |
Other Current Assets
| 2,836.1 | 2,135.2 | -0.1 | -0.1 | 0.2 | 1,761.4 | 2,680.8 | -0.1 | -0.001 | 4,811.429 | 4,204.351 | 3,492.2 | 3,817.293 | 3,163.696 |
Total Current Assets
| 30,785.6 | 29,100.2 | 28,607.9 | 25,779 | 24,627.5 | 19,577.3 | 18,247.5 | 13,210.6 | 15,065.632 | 8,907.391 | 7,551.746 | 6,321.593 | 6,875.513 | 5,418.908 |
Non-Current Assets: | ||||||||||||||
Property, Plant & Equipment, Net
| 30,710.7 | 29,997.3 | 39,472.6 | 36,480.3 | 30,990.1 | 24,399.9 | 18,377.6 | 11,686.8 | 8,237.453 | 5,947.316 | 4,176.298 | 3,764.833 | 3,260.616 | 2,984.957 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 36 | 37.7 | 0 | 435.585 | 352.807 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 1,548.2 | 3,229.5 | 2,990.2 | 2,662.7 | 1,619.7 | 270 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| -0.1 | 0 | 1,548.2 | 3,229.5 | 2,990.2 | 2,698.7 | 1,657.4 | 270 | 435.585 | 352.807 | 0 | 0 | 0 | 0 |
Long Term Investments
| 930.2 | 963.3 | 1,184 | 493.1 | 176.2 | 487.6 | 294.6 | 498.8 | 867.3 | 22.641 | 33.557 | 33.028 | 0 | 0 |
Tax Assets
| 1,696.4 | 1,230.1 | 58.8 | 1,108 | 1,106.6 | 148.5 | 121.8 | 552.9 | 238.1 | -22.641 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 333 | 537.4 | 348.8 | -0.1 | -0.1 | 467.3 | 711.4 | 647.7 | -250.268 | 1,204.161 | 416.416 | 358.788 | 382.912 | 32.617 |
Total Non-Current Assets
| 33,670.2 | 32,728.1 | 42,612.4 | 41,310.8 | 35,263 | 28,202 | 21,162.8 | 13,656.2 | 9,528.17 | 7,504.284 | 4,626.271 | 4,156.649 | 3,643.528 | 3,017.574 |
Total Assets
| 64,455.8 | 61,828.3 | 71,220.3 | 67,089.8 | 59,890.5 | 47,777.6 | 39,410.5 | 26,866.8 | 24,593.802 | 16,411.675 | 12,178.018 | 10,478.242 | 10,519.041 | 8,436.482 |
Liabilities & Equity: | ||||||||||||||
Current Liabilities: | ||||||||||||||
Account Payables
| 7,356.4 | 6,798.1 | 7,063.9 | 6,687.7 | 6,259.3 | 50.9 | 2 | 11.5 | 8.798 | 9.632 | 8.831 | 5.565 | 2,091.453 | 0 |
Short Term Debt
| 4,502.8 | 6,527.9 | 6,449.7 | 3,121.8 | 8,704 | 6,291.3 | 2,077.8 | 885.2 | 1,564.178 | 2,446.988 | 571.775 | 1,162.569 | 1,394.577 | 0 |
Tax Payables
| 0 | 0 | 0 | 21.5 | 0 | 36.1 | 0 | 97.9 | 92.6 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 157.6 | 2,187.9 | 3,651.8 | 2,998.7 | 2,133.8 | 8,340.6 | 94.7 | 5,891 | 6,100.624 | 4,383.339 | 3,893.561 | 3,243.349 | 356.634 | 0 |
Other Current Liabilities
| 2,533.1 | 855.4 | -0.1 | 0.2 | 418.9 | 213.5 | 9,060.4 | -0.2 | 0.714 | 0.944 | 4.942 | 4.803 | 1,505.724 | 2,136.314 |
Total Current Liabilities
| 14,549.9 | 16,369.3 | 17,165.3 | 12,808.4 | 17,516 | 14,896.3 | 11,234.9 | 6,787.5 | 7,674.314 | 6,840.903 | 4,479.109 | 4,416.286 | 5,348.388 | 2,136.314 |
Non-Current Liabilities: | ||||||||||||||
Long Term Debt
| 628.8 | 692.3 | 721.4 | 2,714.3 | 9,602.9 | 4,993 | 5,000 | 0 | 0 | 188 | 522.2 | 705.347 | 948.567 | 3,279.076 |
Deferred Revenue Non-Current
| -1,312.8 | -831.4 | -1,976.9 | 855.2 | 745.1 | 520.3 | 616.6 | 0 | 0 | 93.615 | 66.806 | 60.606 | 53.904 | 0 |
Deferred Tax Liabilities Non-Current
| 1,312.8 | 831.4 | 1,976.9 | 42.1 | 121.9 | 187.5 | 354.4 | 369.3 | 501.287 | 314.334 | 227.17 | 138.969 | 95.29 | 53.746 |
Other Non-Current Liabilities
| 1,095.1 | 1,062 | 958.1 | 0.1 | 0.1 | 0.2 | 0.1 | 697.8 | 412.805 | 128.439 | 127.037 | 127.607 | 122.908 | 14.508 |
Total Non-Current Liabilities
| 1,723.9 | 1,754.3 | 1,679.5 | 3,611.7 | 10,470 | 5,701 | 5,971.1 | 1,067.1 | 914.092 | 724.388 | 943.213 | 1,032.529 | 1,220.669 | 3,347.33 |
Total Liabilities
| 16,273.8 | 18,123.6 | 18,844.8 | 16,420.1 | 27,986 | 20,597.3 | 17,206 | 7,854.6 | 8,588.406 | 7,565.291 | 5,422.322 | 5,448.815 | 6,569.057 | 5,483.644 |
Equity: | ||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 52,508.7 | 44,066.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 393.1 | 393.1 | 393.1 | 393.1 | 377 | 377 | 377 | 377 | 377.032 | 377.032 | 377.032 | 377.032 | 377.032 | 377.032 |
Retained Earnings
| 40,270.2 | 35,684.4 | 25,543.9 | 24,241 | 15,386.4 | 12,868.7 | 9,370 | 7,181.8 | 7,136.2 | 8,373.566 | 6,234.995 | 4,582.435 | 822.974 | 0 |
Accumulated Other Comprehensive Income/Loss
| 47,788.9 | 335.4 | 18,808.8 | 18,513.8 | -4,951.5 | -3,513.8 | -2,455.4 | -4,554.4 | -3,878.237 | -3,141.88 | -2,681.209 | -2,282.569 | -1,950.891 | -1,615.453 |
Other Total Stockholders Equity
| -40,270.2 | 7,291.8 | 7,629.7 | 8,128.2 | -31,126.5 | -26,610.6 | 14,909.8 | 16,006.7 | 12,370.401 | 3,237.666 | 2,824.878 | 2,352.529 | 4,700.869 | 4,191.259 |
Total Shareholders Equity
| 48,182 | 43,704.7 | 52,375.5 | 51,276.1 | 32,194.1 | 27,188.2 | 22,201.4 | 19,011.1 | 16,005.396 | 8,846.384 | 6,755.696 | 5,029.427 | 3,949.984 | 2,952.838 |
Total Equity
| 48,182 | 43,704.7 | 52,375.5 | 50,669.7 | 31,904.5 | 27,180.3 | 22,204.5 | 19,012.2 | 16,005.396 | 8,846.384 | 6,755.696 | 5,029.427 | 3,949.984 | 2,952.838 |
Total Liabilities & Shareholders Equity
| 64,455.8 | 61,828.3 | 71,220.3 | 67,089.8 | 59,890.5 | 47,777.6 | 39,410.5 | 26,866.8 | 24,593.802 | 16,411.675 | 12,178.018 | 10,478.242 | 10,519.041 | 8,436.482 |